| |
|
|
|
|
|
|
|||
|
Blood, 1 May 2006, Vol. 107, No. 9, pp. 3761-3763. Prepublished online as a Blood First Edition Paper on January 10, 2006; DOI 10.1182/blood-2005-06-2235.
TRANSFUSION MEDICINE Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)From the Department of Transfusion Medicine, University of Rostock, Germany; Departments of Pediatrics (Neonatology Division) and Transfusion Medicine, McMaster University, Hamilton, ON, Canada; Institute for Clinical Immunology and Transfusion Medicine, University of Giessen, Giessen, Germany; Institute for Transfusion Medicine and Hemostaseology, University of Düsseldorf, Germany; Institute for Transfusion Medicine, German Red Cross Blood Transfusion Service, Dresden, Germany; Department of NeonatologyOtto Heubner Centre, Charité Campus Virchow, Berlin, Germany; Department of Neonatology and Pediatric Intensive Care, Asklepios Clinic, St Augustin, Germany; Department of Transfusion Medicine, Helios Clinic, Schwerin, Germany; Institute for Experimental Hematology and Transfusion Medicine, University of Bonn, Germany; and Institute for Immunology and Transfusion Medicine, University of Greifswald, Germany.
Neonatal alloimmune thrombocytopenia (NAIT) is a fetomaternal incompatibility most commonly induced by maternal anti-HPA-1a, IgG alloantibodies against a polymorphic epitope of the glycoprotein IIb/IIIa complex in approximately 97.5% of white patients. Current guidelines recommend transfusion of immunologically compatible platelets to prevent cerebral hemorrhage, the most severe complication in affected newborns. Such platelet concentrates, however, are often not readily available. In a retrospective analysis in German and Canadian centers, 27 newborns with NAIT were identified who received platelets from random donors. Unexpectedly, 24 of 27 newborns showed an increase above a threshold of 40 x 109 platelets per liter, with moderate (n = 8) or significant (n = 16) platelet count increments (more than 80 x 109/L). We conclude that transfusion of platelet concentrates from random donors is an appropriate strategy in the management of unexpected, severe NAIT predominantly in first pregnancies, pending the availability of compatible platelets.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||